Clinical trial
The Effect of The STEADI Program on Falls and Falls Prevention in Neurosurgical Patients in Jordan
Name
92-2023
Description
The goal of this interventional study will be to evaluate the effectiveness of the STEADI Program on falls and falling prevention compared with routine falling assessment in neurosurgical patients in Jordan. The researchers will compare the effectiveness of the STEADI intervention in the intervention group. Participants in the intervention group will be assessed for falls risk using well-established tools as recommended by the Centers for Disease Control and Prevention (CDC). The control group participants will receive regular falling assessment which involves using Morse Fall Scale.
Trial arms
Trial start
2023-03-01
Estimated PCD
2023-07-31
Trial end
2023-08-31
Status
Completed
Treatment
STEADI Program
The investigators will conduct STEADI Algorithm for Falls Prevention educational sessions for healthcare providers in the neurosurgery unit, including doctors, nurses, physical therapists, and pharmacists. All healthcare providers in the neurosurgery unit will be invited to attend the educational sessions. Their participation will be voluntary and no obligations will be made, though. Healthcare providers will be invited to attend one 2-hour educational session. In each session, The investigators will have between 8-10 healthcare providers. The educational sessions will be delivered in the classroom available in the neurosurgery unit to facilitate the healthcare providers' access. PowerPoint presentations, videos, quizzes, case studies, and in-class discussions will be used to deliver learning content during the educational sessions. Healthcare providers will then be asked to apply the STEADI interventions on a group of patients.
Arms:
Intervention
Routine care
The control group participants will receive routine care. Routine care involves only assessing for falls using Morse Falls Scale (MFS). MFS assesses a patient's fall risk upon admission, following a change in status, and at discharge or transfer to a new setting.
Arms:
Control
Size
70
Primary endpoint
The Stay Independent Brochure (SIB)
Change from baseline to 5-days and 1-month
The clinician's 3 key questions
Change from baseline to 5-days and 1-month
Time Up and Go (TUG)
Change from baseline to 5-days and 1-month
30-Second Chair Stand
Change from baseline to 5-days and 1-month
The 4-Stage Balance test
Change from baseline to 5-days and 1-month
Actual falls
At final (1-month) assessment
Eligibility criteria
Inclusion Criteria:
* Newly admitted patients to the neurosurgery unit as a case of neurosurgery, have ≥4 scores on the Stay Independent Brochure (SIB), 18 years old or older.
Exclusion Criteria:
* Bedridden and unconscious/comatose patients
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['NA'], 'designInfo': {'allocation': 'NON_RANDOMIZED', 'interventionModel': 'PARALLEL', 'interventionModelDescription': 'This study will be conducted using a 1-month prospective quasi-experimental design.\n\nThe study sample will be 70 neurosurgical patients at King Abdullah University Hospital. The study sample will be non-randomly divided into a control group (35 patients) and an intervention group (35 patients).', 'primaryPurpose': 'PREVENTION', 'maskingInfo': {'masking': 'NONE'}}, 'enrollmentInfo': {'count': 70, 'type': 'ACTUAL'}}
Updated at
2023-09-06
1 organization
Organization
King Abdullah University Hospital